NIDA Notes Archives

This is Archived content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). For current information, please visit nida.nih.gov.

For 30 years, NIDA Notes provided in-depth coverage of research findings on drug misuse and addiction. NIDA Notes was discontinued in 2021.  

Bulletin Board

 |  New Leader Named for NIDA's Neuroscience and Behavioral Research Division Dr. Glen R. Hanson Dr. Glen R. Hanson is the new director of NIDA's Division of Neuroscience and Behavioral Research...

Cues Trigger Craving

 |  To evaluate the impact of the urge to smoke on craving for other drugs, Dr. Stephen Heishman and his colleagues asked participants to rate their desires for tobacco and other...

Bulletin Board

 |  NIDA Grantee Wins Biological Society Award Dr. Ming T. Tsuang Dr. Ming T. Tsuang, a NIDA-supported researcher at Harvard University in Cambridge, Massachusetts, has won the Society of Biological Psychiatry's...

Treating the Brain in Drug Abuse

 |  Remarkable research and technological advances in the past two decades have proved that brain disruption and damage play central roles in the consequences of drug abuse and addiction. Knowing the...

Bulletin Board

 |  Buprenorphine Development Team Honored Members of the buprenorphine development team in NIDA's Division of Treatment Research and Development with Secretary of Health and Human Services Donna Shalala. From left to...

Bulletin Board

 |  NIDA Researcher Wins Endowed Chair at Yale Dr. Edward H. Kaplan, a NIDA-funded investigator, professor of public health at the Yale University Medical School, and professor of management sciences at...

NIDA Reaches Out to the Nation

 |  At the Seattle Town Meeting, NIDA Director Dr. Alan I. Leshner (right) is joined by (left to right) Michael Kreidler, Region 10 administrator for the Department of Health and Human...

NIDA's Epidemiological Compasses

 |  Epidemiology is the science of identifying trends and patterns in the occurrence of health problems. Epidemiological studies advance NIDA's mission by gauging the scope and nature of the Nation's drug...

Bulletin Board

 |  Four New Members Join National Advisory Council NIDA's National Advisory Council on Drug Abuse meets three times each year to evaluate applications for NIDA research grants, review recent research findings...

NIDA's Strategic Plan for 2000-2005

 |  Now is a time of extraordinary opportunity in drug abuse science. Thanks to the exemplary research achievements of recent decades, we have advanced from a rudimentary understanding of drug abuse...

About Anabolic Steroid Abuse

 |  NIDA has issued an updated research report that summarizes the latest scientific information on anabolic steroids. The eight-page Research Report, Anabolic Steroid Abuse , is part of a nationwide education...

Bulletin Board

 |  Recovery Harder for Addicts Who Start Young A NIDA-funded study has demonstrated that the relapse rate for heroin addicts increases with time and that the probability of long-run abstinence depends...

A Club Drug Alert

 |  For several years, NIDA monitoring systems have registered a nationwide pattern of drug use centered on all-night party and "rave" dance clubs and bars. The drugs reported in these scenes...

Bulletin Board

 |  Teen Alternative to Cigarettes Has Higher Concentrations of Nicotine Although hand-rolled cigarettes from India, called bidis (pronounced "beedees"), are an increasingly popular alternative to conventional cigarettes among teens in the...

What Are Club Drugs?

 |  MDMA (methylenedioxymethamphetamine): Ecstasy, X, XTC, Adam A stimulant similar to methamphetamine, MDMA is usually taken orally as a tablet. It causes increased heart rate and blood pressure, and may lead...

Poster Presentations by NIDA Investigators

 |  Dr. Frederick Altice discusses his poster with NIDA Director, Dr. Alan I. Leshner. Dr. Leslie Amass of the University of Colorado School of Medicine in Denver described preliminary results of...

Facts About Drug Abuse and Hepatitis C

 |  What is Hepatitis C? Hepatitis C, a viral disease that destroys liver cells, is the most common blood-borne infection in the United States. Approximately 36,000 new cases of acute hepatitis...

Bulletin Board

 |  Dr. Lula Beatty Commended by Historically Black Colleges Dr. Lula Beatty, NIDA's chief of special populations, was honored with an "Enduring Contributions in the Interest of Science Award" at the...

The State of the Art in Drug Addiction Treatment

 |  NIDA's recent publication, Principles of Drug Addiction Treatment: A Research-based Guide, distills the lessons of 25 years of scientific investigation. Principles is written for health care providers, to stimulate their...

Bulletin Board

 |  NIDA Director Receives Honorary Degree NIDA Director Dr. Alan I. Leshner has received an honorary doctorate of science from his alma mater, Franklin and Marshall College in Lancaster, Pennsylvania. At...

Facts About MDMA (Ecstasy)

 |  MDMA (3,4-methylenedioxymethamphetamine) has a chemical structure similar to the stimulant methamphetamine and the hallucinogen mescaline and can produce both stimulant and psychedelic effects. Reportedly, MDMA's psychedelic effects are milder than...

Targeting Methamphetamine Abuse

 |  While the popularity of methamphetamine, a powerful and highly addictive stimulant, has waxed and waned over the years, NIDA-supported scientific research has continued to serve as the basis for the...

Bulletin Board

 |  NIDA Scientist Granted Honorary Degree by Italian University Dr. Roy Wise Dr. Roy Wise of NIDA's Intramural Research Program in Baltimore was awarded an honorary doctorate in medicine by the...

Tracking Trends in Drug Abuse

 |  NIDA's Community Epidemiology Work Group (CEWG) was established in 1976 to analyze and report on current patterns and developing trends in drug abuse. Using data ranging from wide-scale to street-level...

Infectious Diseases and Drug Abuse

 |  Drug abuse involves health risks that often are as dangerous as the physiological effects of the drugs themselves. Injecting drug users (IDUs) are at high risk for direct exposure to...